Sickle-cell disease is the most prevalent genetic hematologic condition in the United States. Numerous studies have demonstrated poor growth and delayed maturation in children with homozygous sickle-cell disease; however, the pathophysiology remains inadequately understood. Affected children have normal weight and length at birth, and then around 6 months of age their growth patterns begin to diverge from the norm. The growth deficits experienced by these children remain a problem with clinical significance and intangible consequences. A review of literature has provided insight into the multifactorial basis of the growth failure experienced by this population. It is important that nurses and health care providers are familiar with the growth patterns unique to sickle-cell disease and recognize their role in clinical practice.
Al-SaqladiA.CipolottiR.FijnvandraatK.BrabinB. J. (2008). Growth and nutritional status of children with homozygous sickle cell disease. Annals of Tropical Paediatrics, 28, 165-189. doi:10.1179/146532808X335624
BallasS. K.LieffS.BenjaminL. J.DampierC. D.HeeneyM. M.HoppeC.TelenM. J.; Investigators, Comprehensive Sickle Cell Centers. (2010). Definitions of the phenotypic manifestations of sickle cell disease. American Journal of Hematology, 85, 6-13.
4.
BuisonA. M.KawchakD. A.SchallJ.Ohene-FrempongK.StallingsV. A.ZemelB. S. (2004). Low vitamin D status in children with sickle cell disease. Journal of Pediatrics, 145, 622-627.
Collett-SolbergP. F.FleenorD.SchultzW. H.WareR. E. (2007). Short stature in children with sickle cell anemia correlates with alterations in the IGF-I axis. Journal of Pediatric Endocrinology & Metabolism, 20, 211-218.
7.
Committee on Infectious Diseases. (1993). Vitamin A treatment of measles. Pediatrics, 91, 1014-1015.
8.
FrenetteP. S.AtwehG. F. (2007). Sickle cell disease: Old discoveries, new concepts, and future promise. Journal of Clinical Investigation, 117, 850-858.
9.
FungE. B.KawchakD. A.ZemelB. S.RovnerA. J.Ohene-FrempongK.StallingsV. A. (2008). Markers of bone turnover are associated with growth and development in young subjects with sickle cell anemia. Pediatric Blood & Cancer, 50, 620-623.
10.
HibbertJ. M.CrearyM. S.GeeB. E.BuchananI. D.QuarshieA.HsuL. L. (2006). Erythropoiesis and myocardial energy requirements contribute to the hypermetabolism of childhood sickle cell anemia. Journal of Pediatric Gastroenterology and Nutrition, 43, 680-687.
KawchakD. A.SchallJ. I.ZemelB. S.Ohene-FrempongK.StallingsV. A. (2007). Adequacy of dietary intake declines with age in children with sickle cell disease. Journal of the American Dietetic Association, 107, 843-848. doi:10.1016/j.jada.2007.02.015
LalA.FungE. B.PakbazZ.Hackney-StephensE.VichinskyE. P. (2006). Bone mineral density in children with sickle cell anemia. Pediatric Blood & Cancer, 47, 901-906.
15.
National Institutes of Health. (2006). Dietary supplement fact sheet: Vitamin A and carotenoids [Office of Dietary Supplements Health Professional Fact Sheet]. Retrieved from http://ods.od.nih.gov/factsheets/vitamina.asp
16.
National Institutes of Health. (2009a). Dietary supplement fact sheet: Calcium [Office of Dietary Supplements Health Professional Fact Sheet]. Retrieved from http://ods.od.nih.gov/factsheets/calcium.asp
17.
National Institutes of Health. (2009b). Dietary supplement fact sheet: Zinc [Office of Dietary Supplements Health Professional Fact Sheet]. Retrieved from http://ods.od.nih.gov/factsheets/Zinc.asp
18.
National Institutes of Health. (2009c). Dietary supplement fact sheet: Vitamin D [Office of Dietary Supplements Health Professional Fact Sheet]. Retrieved from http://ods.od.nih.gov/factsheets/vitamind.asp
19.
RhodesM.AkohoueS. A.ShankarS. M.FlemingI.Qi AnA.YuC.BuchowskiM. S. (2009). Growth patterns in children with sickle cell anemia during puberty. Pediatric Blood & Cancer, 53, 635-641.
20.
SchallJ. I.ZemelB. S.KawchakD. A.Ohene-FrempongK.StallingsV. A. (2004). Vitamin A status, hospitalizations, and other outcomes in young children with sickle cell disease. Journal of Pediatrics, 145, 99-106.
21.
SilvaC. M.VianaM. B. (2002). Growth deficits in children with sickle cell disease. Archives of Medical Research, 33, 308-312.
22.
SmileyD.Dagogo-JackS.UmpierrezG. (2008). Therapy insight: Metabolic and endocrine disorders in sickle cell disease. Nature Clinical Practice. Endocrinology & Metabolism, 4, 102-109.
23.
WagnerC. L.GreerF. R., the American Academy of Pediatrics Section on Breastfeeding, & the American Academy of Pediatrics Committee on Nutrition. (2008). Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics, 122, 1142-1152.
24.
WangW. C.MoralesK. H.ScherC. D.StylesL.OlivieriN.AdamsR. (2005). Effect of long-term transfusion on growth in children with sickle cell anemia: Results of the STOP trial. Journal of Pediatrics, 147, 244-247.
25.
ZemelB. (2009). The recognition and treatment of growth disorders—A 50-year retrospective. Annals of Human Biology, 36, 496-510.
26.
ZemelB. S.KawchakD. A.FungE. B.Ohene-FrempongK.StallingsV. A. (2002). Effect of zinc supplementation on growth and body composition in children with sickle cell disease. American Journal of Clinical Nutrition, 75, 300-307.
27.
ZemelB. S.KawchakD. A.Ohene-FrempongK.SchallJ. I.StallingsV. A. (2007). Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatric Research, 61(5, Pt. 1), 607-613.
